Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Maraganore

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Texas Heart Institute Journal|January 1, 1993
The arterial thrombotic process and emerging drugs for its controlJ M Maraganore
Thrombosis and Haemostasis|July 1, 1993
Thrombin, thrombin inhibitors, and the arterial thrombotic processJ M Maraganore
Advances in Experimental Medicine and Biology|January 1, 1993
Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitorJ M Maraganore
Methods in Enzymology|January 1, 1993
Hirudin and hirudin-based peptidesS R Stone, J M Maraganore
Advances in Experimental Medicine and Biology|January 1, 1990
Thrombin inhibition by synthetic hirudin peptidesJ M Maraganore, J W Fenton
Blood|January 15, 1990
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudinJ A Jakubowski, J M Maraganore
The Journal of Biological Chemistry|April 15, 1986
The lysine-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to other phospholipases A2J M Maraganore, R L Heinrikson
The Journal of Biological Chemistry|March 15, 1993
The lysine-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to other phospholipases A2J M Maraganore, R L Heinrikson
Coronary Artery Disease|June 1, 1996
Hirulog: a direct thrombin inhibitor for management of acute coronary syndromesJ M Maraganore, B A Adelman
Biochemical and Biophysical Research Communications|August 30, 1985
The role of lysyl residues of phospholipases A2 in the formation of the catalytic complexJ M Maraganore, R L Heinrikson
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Texas Heart Institute Journal|January 1, 1993
The arterial thrombotic process and emerging drugs for its controlJ M Maraganore
Thrombosis and Haemostasis|July 1, 1993
Thrombin, thrombin inhibitors, and the arterial thrombotic processJ M Maraganore
Advances in Experimental Medicine and Biology|January 1, 1993
Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitorJ M Maraganore
Methods in Enzymology|January 1, 1993
Hirudin and hirudin-based peptidesS R Stone, J M Maraganore
Advances in Experimental Medicine and Biology|January 1, 1990
Thrombin inhibition by synthetic hirudin peptidesJ M Maraganore, J W Fenton
Blood|January 15, 1990
Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudinJ A Jakubowski, J M Maraganore
The Journal of Biological Chemistry|April 15, 1986
The lysine-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to other phospholipases A2J M Maraganore, R L Heinrikson
The Journal of Biological Chemistry|March 15, 1993
The lysine-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to other phospholipases A2J M Maraganore, R L Heinrikson
Coronary Artery Disease|June 1, 1996
Hirulog: a direct thrombin inhibitor for management of acute coronary syndromesJ M Maraganore, B A Adelman
Biochemical and Biophysical Research Communications|August 30, 1985
The role of lysyl residues of phospholipases A2 in the formation of the catalytic complexJ M Maraganore, R L Heinrikson
Pageof 5